CompletedNot Applicable

Preliminary Study 1 to Test the Effects of Ambulatory Voice Biofeedback

United States29 participantsStarted 2017-09-27

Plain-language summary

This first study will enroll 3 groups of patients with vocal fold nodules that will receive different schedules of ambulatory voice biofeedback (100% frequency feedback, 25% frequency feedback, summary feedback) to avoid their upper 15th percentile of vocal loudness.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with vocal fold nodules Exclusion Criteria: Non-English speakers are excluded because prompts on the smartphone app are only available in English

What they're measuring

Percent Compliance

Timeframe: 1 week

Trial details

NCT IDNCT03416829

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-30

Results submitted2022-08-22

View on ClinicalTrials.gov More Vocal Fold Nodules trials